{
  "id": 4023663,
  "title": "Aficamten trial brings positive news for patients living with non-obstructive hypertrophic cardiomyopathy",
  "url": "https://urgent.news/2026/08/28/aficamten-trial-brings-positive-news-for-patients-living-with-non",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-28T19:20:04.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-08-aficamten-trial-positive-news-patients.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Aficamten treatment was associated with significant improvements in symptom burden and exercise capacity in patients with symptomatic non-obstructive hypertrophic cardiomyopathy, according to results presented today in a Hot Line session at ESC Congress 2026 and published simultaneously in the New England Journal of Medicine.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}